Atlas Trials

Study of Ruxolitinib in Colorectal Cancer Patients

Clinical trial NCT02119676 · TERMINATED

Trial details

NCT number
NCT02119676
Sponsor
Incyte Corporation
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
CRC (Colorectal Cancer)
Start date
2014-03-01
Primary completion
2016-02-01
Enrollment
396

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.